Literature DB >> 7624329

Augmented DNA-binding activity of p53 protein encoded by a carboxyl-terminal alternatively spliced mRNA is blocked by p53 protein encoded by the regularly spliced form.

R Wolkowicz1, A Peled, N B Elkind, V Rotter.   

Abstract

DNA-binding activity of the wild-type p53 is central to its function in vivo. However, recombinant or in vitro translated wild-type p53 proteins, unless modified, are poor DNA binders. The fact that the in vitro produced protein gains DNA-binding activity upon modification at the C terminus raises the possibility that similar mechanisms may exist in the cell. Data presented here show that a C-terminal alternatively spliced wild-type p53 (ASp53) mRNA expressed by bacteria or transcribed in vitro codes for a p53 protein that efficiently binds DNA. Our results support the conclusion that the augmented DNA binding activity of an ASp53 protein is probably due to attenuation of the negative effect residing at the C terminus of the wild-type p53 protein encoded by the regularly spliced mRNA (RSp53) rather than acquisition of additional functionality by the alternatively spliced C' terminus. In addition, we found that ASp53 forms a complex with the non-DNA-binding RSp53, which in turn blocks the DNA-binding activity of ASp53. Interaction between these two wild-type p53 proteins may underline a mechanism that controls the activity of the wild-type p53 protein in the cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624329      PMCID: PMC41425          DOI: 10.1073/pnas.92.15.6842

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  A transcriptionally active DNA-binding site for human p53 protein complexes.

Authors:  W D Funk; D T Pak; R H Karas; W E Wright; J W Shay
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Alternatively spliced p53 RNA in transformed and normal cells of different tissue types.

Authors:  K A Han; M F Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

4.  Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses.

Authors:  D Ronen; Y Teitz; N Goldfinger; V Rotter
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

5.  Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Authors:  W E Mercer; M T Shields; D Lin; E Appella; S J Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

6.  A DNA binding domain is contained in the C-terminus of wild type p53 protein.

Authors:  O S Foord; P Bhattacharya; Z Reich; V Rotter
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

Review 7.  How loops, beta sheets, and alpha helices help us to understand p53.

Authors:  C Prives
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

Review 8.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells.

Authors:  Y Wu; Y Liu; L Lee; Z Miner; M Kulesz-Martin
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

10.  The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.

Authors:  J M Slingerland; J R Jenkins; S Benchimol
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  8 in total

1.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.

Authors:  N Almog; R Li; A Peled; D Schwartz; R Wolkowicz; N Goldfinger; H Pei; V Rotter
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

3.  DNA binding specificity of proteins derived from alternatively spliced mouse p53 mRNAs.

Authors:  Z Miner; M Kulesz-Martin
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

4.  Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.

Authors:  M Laverdière; J Beaudoin; A Lavigueur
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

5.  Modulation of alternative splicing contributes to cancer development: focusing on p53 isoforms, p53β and p53γ.

Authors:  H Solomon; M Sharon; V Rotter
Journal:  Cell Death Differ       Date:  2014-09       Impact factor: 15.828

6.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study.

Authors:  R Lev Bar-Or; R Maya; L A Segel; U Alon; A J Levine; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

7.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

8.  Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA.

Authors:  S D Miller; K Moses; L Jayaraman; C Prives
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.